Erasca to Present at Upcoming Investor Conferences

Company Overview - Erasca, Inc. is a clinical-stage precision oncology company focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers [3] - The company aims to "erase cancer" by creating novel therapies and combination regimens that comprehensively target the RAS/MAPK pathway [3] - Erasca has one of the most extensive pipelines in the industry dedicated to the RAS/MAPK pathway, supported by a scientific advisory board of leading experts [3] Upcoming Events - Erasca will participate in the Guggenheim Securities Healthcare Innovation Conference from November 11 to 13, 2024, with a fireside chat scheduled for November 12 at 2:00 pm Eastern Time [2] - The company will also attend the Jefferies London Healthcare Conference from November 19 to 21, 2024, with a presentation on November 20 at 12:30 pm Greenwich Mean Time [2] - Additionally, Erasca will be part of the 7th Annual Evercore HealthCONx Conference from December 3 to 5, 2024, featuring a fireside chat on December 4 at 11:15 am Eastern Time [2] - Live audio webcasts of these events will be available on Erasca's website, with archived replays accessible for 90 days post-event [2]